External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home Neuroscience HSG 2024
Roche and Genentech at

HSG 2024

November 07 - November 09
Cincinnati, USA
huntingtonstudygroup.org
We will be contributing to topics related to
Neuroscience
Add to calendar
Share feedback
Share page
-
Agenda
Medical Materials
03:00 PM
Duration 72hrs Cincinnati, USA
SPK-10001 AAV-based microRNA mediates non-allele specific reduction of HTT mRNA through RNA interference, demonstrating its potential for further preclinical development
Francesca Cargnin, PhD
Neuroscience | Huntington's Disease

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 72hrs Cincinnati, USA
Route to a safe delivery strategy of AAV-based gene therapy ​to the caudate and putamen of nonhuman primates​
Francesca Cargnin, PhD
Neuroscience | Huntington's Disease

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 72hrs Cincinnati, USA
SPK-10001 induces a durable and safe reduction of HTT protein supporting further development in Huntington’s disease​
Francesca Cargnin, PhD
Neuroscience | Huntington's Disease

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
03:00 PM
Duration 5mins Cincinnati, OH
Advancing SPK-10001 into a First-in-Human study
Juha Savola
Neuroscience | Huntington's Disease

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
03:45 PM
Duration 7mins Cincinnati, OH
Clinical Development Update on Tominersen: Fluid biomarker data from GENERATION HD1 and what it means for GENERATION HD2
Peter McColgan
Neuroscience | Huntington's Disease

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Coming soon

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.